Piper Jaffray upgrades Human Genome Sciences (Nasdaq: HGSI) from Neutral to Buy and lowers its price target from $11 to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE